Interview Spotlight Series: Part III

-

This week on Simply Blood we are continuing our 2025 Interview Spotlight Series. In part III, we are featuring the ISEH 2025 McCulloch and Till Award Winner: Ulrich Steidl, MD, PhD. Dr. Steidl dives into his current work, career inspirations, and advice for the young generation of science. Interested in hearing more about Dr. Steidl's fascinating work? Don’t miss his session at the ISEH 54th Annual Scientific Meeting this September!




Ulrich Steidl, MD, PhD
Professor, Department of Cell Biology
Professor, Department of Oncology
Professor, Department of Medicine
Chair, Department of Cell Biology
Edward P. Evans Endowed Professor for Myelodysplastic Syndromes
Co-Director, Blood Cancer Institute
Deputy Director, and Associate Director for Basic Science, Montefiore Einstein Comprehensive Cancer Center



Read more about Dr. Steidl's work in the 2025 Award Announcement blog.

Blog post contributed by Vu Tran of the ISEH New Investigators Committee.

Please note that the statements made by Simply Blood authors are their own views and not necessarily the views of ISEH. ISEH disclaims any or all liability arising from any author's statements or materials.

Comments

Post a Comment

Popular posts from this blog

Transition from academia to industry: An interview with Elizabeth Paik

-
Image
We have all read many articles about the possible career choices of a scientist. The usual dilemma is between industry and academia. We have talked about this in previous blogs but the more information we get the easier it is to make a wise choice. Of course we all have opinions about the pros and cons of such a choice but what I always find best is to ask people who have experienced both. That is why I turned to an old colleague and friend, Elizabeth Paik, and asked her some questions regarding her experiences in both academia and industry. Can you describe to us your scientific career? I started my career at Harvard Medical School, as a graduate student in Dr. Len Zon's laboratory. My thesis work focused on understanding a role of CDX transcription factors during embryonic hematopoiesis. Through ChIP-seq, knockdown and overexpression studies in zebrafish, I showed CDX transcription factors control expression of hematopoietic transcription factors - SCL and LMO2. Towards the...
Read more

ISEH 2025 Society Award Winners

-
Image
  On behalf of the Awards Committee, ISEH would like to congratulate the recipients of the 2025 ISEH Society Awards which will be presented at the  ISEH 54th Annual Scientific Meeting . Donald Metcalf Award Winner - Constanze Bonifer The recipient of the 2025 Donald Metcalf Award is Dr. Constanze ‘Conny’ Bonifer, for her outstanding work in the fields of epigenetic and gene regulatory processes regulating blood cell development and differentiation, and how these processes go astray in the development of blood cancer. Dr. Bonifer has been a pioneer and world leader in these areas and a source of inspiration and guidance for many scientists working in experimental hematology.  Dr. Bonifer started her scientific career in Germany where she completed her BSc in Cologne and her PhD in Heidelberg. After a postdoctoral fellowship at the Karolinska Institute, Stockholm, Sweden and the National Institute of Medical Research, London, UK, Dr. Bonifer returned to Germany as an Assist...
Read more

New Culture Methods in Experimental Hematology

-
Image
  The ability to expand hematopoietic stem cells (HSCs) ex vivo has broad clinical and translational potential, and there has been substantial progress in the development of advanced culture systems. Experimental Hematology offers a timely special issue “New Culture Methods in Experimental Hematology”, and two of the reviews specifically address the bone marrow (BM) microenvironment and ex vivo HSC expansion technologies respectively. Busch et al[1] provide a comprehensive summary of the BM microenvironment, covering cellular as well as extracellular components and how these interact. The complexity and challenges of three-dimensional approaches to model the BM niche are described.  The review by Meaker and Wilkinson[2] provides an in-depth analysis of ex vivo expansion of HSCs. This is a key technology for basic research questions and has the potential to improve HSC transplantation and gene therapies in the future. Along these lines there have been important steps taken to a...
Read more